PACU Stay After Lower Limb Revascularisation

Perioperative, Enhanced Recovery Clinical Trial

Official title:

Perioperative Mechanisms for Postoperative Function - Case of Lower Extremities Revascularisation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02726412
• Other study ID #: PACU revascularisation 2016
• Status: Completed
• Phase: N/A
• First received: March 29, 2016
• Last updated: April 25, 2017
• Start date: February 2016
• Est. completion date: June 2016

Study information

• Verified date: April 2017
• Source: Rigshospitalet, Denmark
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study aims to describe the postoperative functions of patients with ischaemic lower extremities after undergoing revascularisation surgery . Primary endpoints will focus on complications in the post-anaesthesia care unit (PACU) which prevent discharge from PACU to the general ward. This include Aldrete scores and other complications that can be registrered descriptively. Furthermore, the study seeks to compare the complications outcomes between acute and elective revascularisation surgery.

Description:

As above

Recruitment information / eligibility

• Status: Completed
• Enrollment: 156
• Est. completion date: June 2016
• Est. primary completion date: June 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients with symptoms of ischaemic lower extremities for instance intermittent claudication, resting leg pain, non-healing/gangrenouswounds and acute cold leg.

• Patients who underwent one or more of the following surgical procedure: PTA + TEA, TEA, bypass, thrombectomy, embolectomy, femoral-femoral crossover bypass, axillary-femoral bypass.

Exclusion Criteria:

• Only PTA intervention

• Only thrombolysis intervention

Related Conditions & MeSH terms

• Perioperative, Enhanced Recovery

Intervention

Procedure:
• Acute vs elective
non-intverention study

Locations

Country	Name	City	State
Denmark	Rigshospitalet, abdominal center	Copenhagen

Sponsors (1)

Lead Sponsor	Collaborator
Rigshospitalet, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Complications assessed by aldrete score		up to 7 days